GlassScriptPhysician profile
Joon B Hur
NPI 1588225833
$1,141.87
in general payments reported to CMS, 2019-2025
17 companies · $97.53 in 2025
The $97.53 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.17 · 2021: $289 · 2022: $223 · 2023: $107 · 2024: $414 · 2025: $97.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $364.76 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $191.20 | 2021-2023 | |
| Rxsight INC | $110.16 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Johnson & Johnson Vision Care, INC. | $93.04 | 2022 | |
| Oyster Point Pharma, INC. | $56.58 | 2022-2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $47.29 | 2021 | |
| Bausch & Lomb Americas INC. | $43.38 | 2023 | Vyzulta |
| Alcon Vision LLC | $38.57 | 2021-2025 | Dailies Total1 |
| Mallinckrodt Hospital Products INC. | $34.05 | 2021 | |
| Biotissue Holdings INC. | $27.23 | 2019-2025 | |
| Eyevance Pharmaceuticals LLC | $25.60 | 2022 | |
| Sun Pharmaceutical Industries INC. | $24.20 | 2021 | |
| Allergan, INC. | $19.46 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.51 | 2021 | |
| Ivantis, INC | $16.47 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $16.38 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joon Hur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.